Literature DB >> 15782303

9alpha-Fluorohydrocortisone therapy in aldosterone synthase deficiency.

Ludwig Stapenhorst.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15782303     DOI： 10.1007/s00467-005-1824-x

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN： 0931-041X            Impact factor:   3.714


× No keyword cloud information.
  5 in total

Review 1.  Technical report: congenital adrenal hyperplasia. Section on Endocrinology and Committee on Genetics.

Authors: 
Journal:  Pediatrics       Date:  2000-12       Impact factor: 7.124

2.  Effect of 9 alpha-fluorohydrocortisone on the hypothalamo-pituitary-adrenal axis.

Authors:  H K Kley; W Geisthövel; H L Krüskemper
Journal:  Acta Endocrinol (Copenh)       Date:  1973-07

3.  The natural history of salt-wasting disorders of adrenal and renal origin.

Authors:  A Rösler
Journal:  J Clin Endocrinol Metab       Date:  1984-10       Impact factor: 5.958

4.  Should we monitor more closely the dosage of 9 alpha-fluorohydrocortisone in salt-losing congenital adrenal hyperplasia?

Authors:  L A Lopes; J M Dubuis; M B Vallotton; P C Sizonenko
Journal:  J Pediatr Endocrinol Metab       Date:  1998 Nov-Dec       Impact factor: 1.634

5.  Rare causes of acute hyperkalemia in the 1st week of life. Three case reports.

Authors:  Vasilios I Giapros; Agathoklis A Tsatsoulis; Ekaterini A Drougia; Konstantinos D Kollios; Ekaterini C Siomou; Styliani K Andronikou
Journal:  Pediatr Nephrol       Date:  2004-06-04       Impact factor: 3.714
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.